387 related articles for article (PubMed ID: 7616005)
1. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Invest Dermatol; 1995 Jul; 105(1 Suppl):89S-94S. PubMed ID: 7616005
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Clin Invest; 1995 Jan; 95(1):317-27. PubMed ID: 7529261
[TBL] [Abstract][Full Text] [Related]
3. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.
Chang EY; Hammerberg C; Fisher G; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
Arch Dermatol; 1992 Nov; 128(11):1479-85. PubMed ID: 1359841
[TBL] [Abstract][Full Text] [Related]
4. UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions.
Baadsgaard O; Tong P; Elder JT; Hansen ER; Ho V; Hammerberg C; Lange-Vejlsgaard G; Fox DA; Fisher G; Chan LS
J Invest Dermatol; 1990 Sep; 95(3):275-82. PubMed ID: 1974570
[TBL] [Abstract][Full Text] [Related]
5. Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets.
Szabo SK; Hammerberg C; Yoshida Y; Bata-Csorgo Z; Cooper KD
J Invest Dermatol; 1998 Dec; 111(6):1072-8. PubMed ID: 9856819
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin and alpha5 integrin regulate keratinocyte cell cycling. A mechanism for increased fibronectin potentiation of T cell lymphokine-driven keratinocyte hyperproliferation in psoriasis.
Bata-Csorgo Z; Cooper KD; Ting KM; Voorhees JJ; Hammerberg C
J Clin Invest; 1998 Apr; 101(7):1509-18. PubMed ID: 9525994
[TBL] [Abstract][Full Text] [Related]
7. Lesional psoriatic T cells contain the capacity to induce a T cell activation molecule CDw60 on normal keratinocytes.
Skov L; Chan LS; Fox DA; Larsen JK; Voorhees JJ; Cooper KD; Baadsgaard O
Am J Pathol; 1997 Feb; 150(2):675-83. PubMed ID: 9033280
[TBL] [Abstract][Full Text] [Related]
8. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop.
Terui T; Ozawa M; Tagami H
Exp Dermatol; 2000 Feb; 9(1):1-10. PubMed ID: 10688368
[TBL] [Abstract][Full Text] [Related]
9. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products.
Prinz JC; Gross B; Vollmer S; Trommler P; Strobel I; Meurer M; Plewig G
Eur J Immunol; 1994 Mar; 24(3):593-8. PubMed ID: 8125129
[TBL] [Abstract][Full Text] [Related]
10. The role of immune system in the pathogenesis of psoriasis.
Baadsgaard O; Fisher G; Voorhees JJ; Cooper KD
J Invest Dermatol; 1990 Nov; 95(5 Suppl):32S-34S. PubMed ID: 16788627
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.
Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ
J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis.
Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD
J Exp Med; 1993 Oct; 178(4):1271-81. PubMed ID: 7690831
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.
Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD
J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367
[TBL] [Abstract][Full Text] [Related]
15. Cellular interactions and adhesion molecules in psoriatic skin.
de Boer OJ; Verhagen CE; Visser A; Bos JD; Das PK
Acta Derm Venereol Suppl (Stockh); 1994; 186():15-8. PubMed ID: 7915480
[TBL] [Abstract][Full Text] [Related]
16. Early migration of cutaneous lymphocyte-associated antigen (CLA) positive T cells into evolving psoriatic plaques.
Davison SC; Ballsdon A; Allen MH; Barker JN
Exp Dermatol; 2001 Aug; 10(4):280-5. PubMed ID: 11493317
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte trafficking in psoriasis: a new perspective emphasizing the dermal dendrocyte with active dermal recruitment mediated via endothelial cells followed by intra-epidermal T-cell activation.
Nickoloff BJ; Griffiths CE
J Invest Dermatol; 1990 Nov; 95(5 Suppl):35S-37S. PubMed ID: 16788628
[TBL] [Abstract][Full Text] [Related]
18. Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction.
Barker JN; Karabin GD; Stoof TJ; Sarma VJ; Dixit VM; Nickoloff BJ
J Dermatol Sci; 1991 Mar; 2(2):106-11. PubMed ID: 1905950
[TBL] [Abstract][Full Text] [Related]
19. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients.
Austin LM; Ozawa M; Kikuchi T; Walters IB; Krueger JG
J Invest Dermatol; 1999 Nov; 113(5):752-9. PubMed ID: 10571730
[TBL] [Abstract][Full Text] [Related]
20. An altered response by psoriatic keratinocytes to gamma interferon.
Baker BS; Powles AV; Valdimarsson H; Fry L
Scand J Immunol; 1988 Dec; 28(6):735-40. PubMed ID: 3148190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
